Skip to main content
Clinical Trials/NCT04304807
NCT04304807CompletedPhase 4

Effect of Melatonin on Feeding Intolerance and Incidence of Necrotizing Enterocolitis in Preterm Infants

Ain Shams University1 site in 1 country90 target enrollmentStarted: December 24, 2018Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Phase 4
Status
Completed
Enrollment
90
Locations
1
Primary Endpoint
Melatonin as an antioxidant and free radical scavenger in feeding intolerance in preterm infants

Study Overview

Brief Summary

Assesses the efficacy of melatonin in treatment of feeding intolerance in preterm infants, the time needed to reach full enteral intake, the incidence of necrotizing enterocolitis and measures the level of tumor necrosis factor-alpha as a marker of oxidative stress.

Detailed Description

This is a prospective study held on ninety preterm infants in Ain Shams University neonatal intensive care units. All enrolled neonates were suffering from feeding intolerance in the form of abdominal distension, gastric residuals or bloody stools. The first group of forty five infants were given melatonin in addition to traditional antibiotic treatment. The second group of forty five infants were given traditional antibiotic treatment only. Both groups were followed up clinically as regards improvement of clinical signs of feeding intolerance and laboratory results till they reached full enteral intake. Both groups were compared as regards incidence of necrotizing enterocolitis and level of tumor necrosis factor-alpha after 72 hours of starting treatment as a marker of oxidative stress.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Preterm infants (<37 weeks of gestation)
  • Evidence of feeding intolerance

Exclusion Criteria

  • Infants with hypoxic ischemic encephalopathy
  • Infants on nothing per os
  • Infants with high oxygen needs wither on invasive or non-invasive mechanical ventilation
  • Major congenital anomalies
  • Intracranial hemorrhage
  • Respiratory distress syndrome

Arms & Interventions

Group I

Experimental

Forty five preterm infants with signs of feeding intolerance who received 20 mg of melatonin treatment in addition to traditional antibiotic treatment.

Intervention: Melatonin 20 mg (Drug)

Group II

Sham Comparator

Forty five preterm infants with signs of feeding intolerance who received traditional antibiotic treatment only.

Intervention: Traditional antibiotic treatment (Drug)

Outcomes

Primary Outcomes

Melatonin as an antioxidant and free radical scavenger in feeding intolerance in preterm infants

Time Frame: 3 days

Melatonin efficacy in treatment of oxidative stress in preterm infants with feeding intolerance was assessed by measuring level of tumor necrosis factor- alpha.

Melatonin efficacy in reducing incidence of necrotizing enterocolitis in preterm infants

Time Frame: 1 week

Melatonin efficacy in reducing incidence of necrotizing enterocolitis by radiological criteria: abdominal ultrasound showing pneumatosis intestinalis.

Effect of melatonin on time needed to reach full enteral intake in preterm infants with feeding intolerance

Time Frame: 2 weeks

Preterm infants with feeding intolerance were observed for the time needed to reach full enteral intake.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Mona Mostafa El-Gammall

Resident of pediatrics and neonatology

Ain Shams University

Study Sites (1)

Loading locations...

Similar Trials